Clinical Trial Update: Vascular Response to Isoproterenol and β2 Adrenergic Receptor Polymorphisms [NA]

View source ↗

Summary

A completed clinical trial studying how isoproterenol affects vascular response in individuals with different β2 adrenergic receptor polymorphisms, in coronary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Isoproterenol (isoproterenol)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Coronary Disease | NA | Status: COMPLETED